Docxis Life Sciences Private Limited

Docxis Life Sciences Private Limited - chemicals in Delhi, India. Directors, charges & compliance details.
CIN U24299DL2022PTC400118 Incorporated 16 June 2022 ROC Delhi HQ Delhi, India
Active Private Limited Company chemicals
Data last updated
Revenue · FY 2025
₹1.51 Cr
▼ 16% YoY
Net profit · FY 2025
₹3.11 Lakh
Net margin 2.1%
EBITDA · FY 2025
₹8.29 Lakh
EBITDA margin 5.5%
Authorised capital
₹35 Lakh
Registered with MCA
Paid-up capital
₹35 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Docxis Life Sciences Private Limited

Data last updated:

Docxis Life Sciences Private Limited is a private limited company based in Delhi, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 16 June 2022.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2022PTC400118.

The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹35 Lakh. It is led by directors Ajeet Mishra and Suman.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 22 Milap Nagar Uttam Nagar, Delhi, India – 110049.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.51 Cr, a decline of 16% compared to the previous year. For the same year it recorded a net profit of ₹3.11 Lakh (net margin 2.1%) and EBITDA of ₹8.29 Lakh (EBITDA margin 5.5%).

Company Details of Docxis Life Sciences Private Limited
CIN U24299DL2022PTC400118
Registration Number 400118
Incorporation Date 16 June 2022
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    F – 22 Milap Nagar Uttam Nagar, Delhi, India – 110049
  • Industry
    Chemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
Comprehensive company report
Docxis Life Sciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Docxis Life Sciences Private Limited report

Financials, compliance, directors, charges, ownership and filings for Docxis Life Sciences Private Limited in one report.

Financials from FY 2023 Directors & ownership Charges & compliance

Business Activity of Docxis Life Sciences Private Limited

The main business activity of Docxis Life Sciences is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Docxis Life Sciences Private Limited FY 2025 filings available

Docxis Life Sciences Private Limited reported revenue of ₹1.51 Cr (down 16% YoY) for FY 2025.

Revenue · FY 2025
₹1.51 Cr ▼ 16%
Net profit · FY 2025
₹3.11 Lakh margin 2.1%
EBITDA · FY 2025
₹8.29 Lakh margin 5.5%

Compounded Annual Growth Rate (CAGR) of Docxis Life Sciences Private Limited

Revenue CAGR growth
1 year
▼ 16%
EBITDA CAGR growth
1 year
▼ 85%

Revenue fell 16% in the latest year. EBITDA fell 85% in the latest year. All are worked out from the filed statements.

Financial Statement Summary of Docxis Life Sciences Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations••••••••••••
Other Income••••••••••••
Total Revenue••••••••••••
Cost of Materials Consumed••••••••••••
Employee Benefit Expense••••••••••••
Finance Costs••••••••••••
Depreciation and Amortisation••••••••••••
Other Expenses••••••••••••
Total Expenses••••••••••••
EBITDA₹8.29 Lakh••••••••
Profit Before Tax••••••••••••
Tax Expense••••••••••••
Net Profit (PAT)₹3.11 Lakh••••••••
Balance Sheet
Share Capital••••••••••••
Reserves and Surplus••••••••••••
Net Worth (Total Equity)••••••••••••
Long-term Borrowings••••••••••••
Short-term Borrowings••••••••••••
Trade Payables••••••••••••
Total Liabilities••••••••••••
Fixed Assets••••••••••••
Investments••••••••••••
Inventories••••••••••••
Trade Receivables••••••••••••
Cash and Bank Balance••••••••••••
Total Assets••••••••••••

Financial Ratios of Docxis Life Sciences Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin5.5%••••••••
Net Profit Margin2.1%••••••••
Return on Equity (ROE)••••••••••••
Return on Capital Employed (ROCE)••••••••••••
Return on Assets (ROA)••••••••••••
Liquidity and Debt
Current Ratio••••••••••••
Quick Ratio••••••••••••
Debt-to-Equity Ratio••••••••••••
Interest Coverage Ratio••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••
Receivable Days••••••••••••
Payable Days••••••••••••
Inventory Days••••••••••••
Revenue Growth••••••••••••
Net Profit Growth••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Docxis Life Sciences are in the company report.

Premium access

Financial statements from FY 2023

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Docxis Life Sciences Private Limited

Docxis Life Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
SumanAdditional Director31 Mar 20233 Years 6 MonthsCurrent
Ajeet MishraDirector16 Jun 20224 Years 3 MonthsCurrent

Charges & Borrowings of Docxis Life Sciences Private Limited

Docxis Life Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Docxis Life Sciences Private Limited

Employment history and EPFO contributions of people linked to Docxis Life Sciences.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Docxis Life Sciences Private Limited

Docxis Life Sciences Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Kapil Madan ceased to be Director on 31 Mar 2023.

AGM
Docxis Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Docxis Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Kapil Madan ceased to be Director.
Appointed
Suman was appointed as Additional Director.
Appointed
Ajeet Mishra was appointed as Director.
Incorporation
16 Jun 2022
Docxis Life Sciences Private Limited was registered on 16 Jun 2022 with Roc Delhi & aged 4 years 3 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Docxis Life Sciences Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Docxis Life Sciences Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Docxis Life Sciences Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Docxis Life Sciences Private Limited

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Docxis Life Sciences Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Docxis Life Sciences Private Limited

Docxis Life Sciences is an active private limited company based in Delhi, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 16 June 2022 (4+ years old) and is registered under CIN U24299DL2022PTC400118.

Docxis Life Sciences reported revenue of ₹1.51 Cr for FY 2025 (down 16% YoY).

Docxis Life Sciences has 2 current directors:

Docxis Life Sciences reported a net profit of ₹3.11 Lakh (net margin 2.1%) and EBITDA of ₹8.29 Lakh (EBITDA margin 5.5%) for FY 2025, as per its filed financial statements.

The CIN (Corporate Identification Number) of Docxis Life Sciences is U24299DL2022PTC400118. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Docxis Life Sciences was incorporated on 16 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.

Kapil Madan ceased to be Director on 31 Mar 2023. Suman was appointed as Additional Director on 31 Mar 2023. Ajeet Mishra was appointed as Director on 16 Jun 2022.

The registered office of Docxis Life Sciences is at F – 22 Milap Nagar Uttam Nagar, Delhi, India – 110049.

Docxis Life Sciences has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹35 Lakh.

Docxis Life Sciences operates in the chemicals industry, in the fine chemicals and other chemical products segment.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available